JamJam Therapeutics announced that it has attracted bridge investment from Smilegate Investment and MYSC (MY Social Company) in the second half of 2024.
JamJam Therapeutics has developed 'JamJam400', an AI motion recognition-based rehabilitation game that helps children with disabilities easily perform rehabilitation exercises without separate equipment. This solution uses AI technology to analyze the movements of the hand and fingers and provides customized rehabilitation exercises. Through a paper with Catholic University, it was proven that it has the same therapeutic effect as existing glove-type hardware products, and it showed the effect of reducing treatment costs by 22 times and increasing the number of exercises by 13 times as it can provide 380 exercise training sessions for the cost of one face-to-face treatment. In addition, JamJam400 can be used immediately after downloading from the App Store and Play Store, increasing the accessibility of rehabilitation exercises.
A Smilegate Investment official said, “JamJam Therapeutics’ AI rehabilitation solution is an innovative technology that is competitive in the global market,” and added, “We will actively support the company’s growth based on our investment experience and expertise in the healthcare field.”
MYSC CEO Kim Jeong-tae said, “I was impressed by the entrepreneurial spirit and sincerity toward solving social problems of the JamJam Therapeutics founding team,” and added, “I will help them grow into a sustainable social venture through our global network and ESG management know-how.”
- See more related articles
You must be logged in to post a comment.